| アブストラクト | BACKGROUND: Women have been under-represented in trials of antipsychotic medications. AIM: Our primary objective was to evaluate five adverse events (AE) associated with first-generation antipsychotics (FGAs) among women relative to men through an analysis of the FDA Adverse Event Reporting System (FAERS). METHOD: We queried 24.6 million AE reports from 2000 to 2023 involving FGAs. The study cohort consisted of chlorpromazine (n = 3317), fluphenazine (n = 1124), haloperidol (n = 16,709), loxapine (n = 3151), perphenazine (n = 816), thioridazine (n = 665), thiothixene (n = 244), and trifluoperazine (n = 360). Cases of neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), Torsades de Pointes (TdP), agranulocytosis (AG), and cerebrovascular adverse events (CVAE) were identified. Reporting odds ratios (ROR) and associated 95% confidence intervals (CI) were calculated with logistic regression for each AE among women relative to men. RESULTS: A total of 2,857 serious AEs were evaluated in the study cohort (NMS = 1810, TD = 434, TdP = 260, AG = 149, CVAE = 204). The ROR for women compared to men was 0.79 (95% CI, 0.71-0.87) for NMS, 0.83 (0.68-1.01) for TD, 1.21 (0.94-1.53) for TdP, 0.71 (0.51-0.98) for AG, and 0.91 (0.68-1.19) for CVAE. A secondary analysis revealed a higher odds in women compared to men of hospitalization associated with reports of TD (ROR = 1.95, 1.29-2.94) and death associated with reports of AG (ROR = 2.46, 1.15-5.24). A subgroup analysis of haloperidol revealed an ROR = 1.67 (1.26-2.21) for women relative to men for TdP. CONCLUSION: The subgroup analysis of haloperidol AEs revealed a significantly higher reporting odds ratio for TdP. Additionally, the secondary study findings suggest that women were more vulnerable to worse outcomes associated with certain AEs of FGAs. |
|---|
| ジャーナル名 | International journal of clinical pharmacy |
|---|
| 投稿日 | 2024/2/5 |
|---|
| 投稿者 | McCall, Kenneth L; Doughty, Bennett J; Piper, Brian J; Naik, Heeral; Bange, Seraphine; Leppien, Emily E |
|---|
| 組織名 | Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences,;Binghamton University, 96 Corliss Avenue, Johnson City, NY, 13790, USA.;kmccall@binghamton.edu.;Department of Medical Education, Geisinger Commonwealth School of Medicine,;Scranton, PA, 18510, USA.;Geisinger Center for Pharmacy Innovation and Outcomes, Daville, PA, 17821, USA.;School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Johnson;City, NY, 13790, USA.;Department of Mathematics and Statistics, Binghamton University, 4400 Vestal Pkwy;E, Binghamton, NY, 13902, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38315306/ |
|---|
